Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pulmonology
Volume 2017 (2017), Article ID 8525789, 4 pages
https://doi.org/10.1155/2017/8525789
Case Report

Daptomycin-Induced Acute Eosinophilic Pneumonia: Late Onset and Quick Recovery

Internal Medicine, Advocate Christ Medical Center, Oak Lawn, IL, USA

Correspondence should be addressed to Mohamad Rachid; moc.liamg@89dihcardemmahom

Received 4 July 2017; Accepted 11 October 2017; Published 1 November 2017

Academic Editor: Shih-Yi Lee

Copyright © 2017 Mohamad Rachid et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. W. Hung, “Minocycline-induced acute eosinophilic pneumonia: A case report and review of the literature,” Respiratory Medicine Case Reports, vol. 15, pp. 110–114, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. J. J. Patel, A. Antony, M. Herrera, and R. J. Lipchik, “Daptomycin-induced acute eosinophilic pneumonia,” Wisconsin Medical Society, vol. 113, pp. 199–201, 2014. View at Google Scholar
  3. E. Cobb, R. C. Kimbrough, K. M. Nugent, and M. P. Phy, “Organizing pneumonia and pulmonary eosinophilic infiltration associated with daptomycin,” Annals of Pharmacotherapy, vol. 41, no. 4, pp. 696–701, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. C. F. Carpenter and H. F. Chambers, “Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens,” Clinical Infectious Diseases, vol. 38, no. 7, pp. 994–1000, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. Cubicin1 (daptomycin) [package insert]. Lexington, MA, USA: Cubist Pharmaceuticals; Revised January 2013.
  6. D. Hayes Jr., M. I. Anstead, and R. J. Kuhn, “Eosinophilic pneumonia induced by daptomycin,” Infection, vol. 54, no. 4, pp. e211–e213, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. P. W. Kim, A. F. Sorbello, R. T. Wassel, T. M. Pham, J. M. Tonning, and S. Nambiar, “Eosinophilic pneumonia in patients treated with daptomycin: Review of the literature and US FDA adverse event reporting system reports,” Drug Safety, vol. 35, no. 6, pp. 447–457, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. A. S. Kalogeropoulos, S. Tsiodras, D. Loverdos, P. Fanourgiakis, and A. Skoutelis, “Eosinophilic pneumonia associated with daptomycin: A case report and a review of the literature,” Journal of Medical Case Reports, vol. 5, article 13, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Camus and P. Foucher, The drug-induced respiratory disease website [Internet], 2012, Dijon, France; 2012. Published June 10, 2012. Updated July 11, 2014. Web site. http://www.pneumotox.com/.
  10. F. Philit, B. Etienne-Mastroïanni, A. Parrot, C. Guérin, D. Robert, and J.-F. Cordier, “Idiopathic acute eosinophilic pneumonia: A study of 22 patients,” American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 9, pp. 1235–1239, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Solomon and M. Schwarz, “Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia,” Seminars in Respiratory and Critical Care Medicine, vol. 27, no. 2, pp. 192–197, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. B. W. Jhun, S. J. Kim, K. Kim, and J. E. Lee, “Clinical implications of initial peripheral eosinophilia in acute eosinophilic pneumonia,” Respirology, vol. 19, no. 7, pp. 1059–1065, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Yusuf, N. Perrottet, C. Orasch, O. Borens, and A. Trampuz, “Daptomycin-associated eosinophilic pneumonia in two patients with prosthetic joint infection,” Surgical Infections, vol. 15, no. 6, pp. 834–837, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. B. A. Miller, A. Gray, T. W. Leblanc, D. J. Sexton, A. R. Martin, and T. G. Slama, “Acute eosinophilic pneumonia secondary to daptomycin: A report of three cases,” Clinical Infectious Diseases, vol. 50, no. 11, pp. e63–e68, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. J. N. Allen, “Drug-induced eosinophilic lung disease,” Clinics in Chest Medicine, vol. 25, no. 1, pp. 77–88, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Shinde, A. Seifi, S. DelRe, W. H. Moustafa Hussein, and J. Ohebsion, “Daptomycin-induced pulmonary infiltrates with eosinophilia,” Infection, vol. 58, no. 2, pp. 173-174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Jantz and S. A. Sahn, “Corticosteroids in acute respiratory failure,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 4, article 1079-100, 1999. View at Google Scholar
  18. M. Hatipoglu, A. Memis, V. Turhan, M. Mutluoglu, and K. Canoglu, “Possible daptomycin-induced acute eosinophilic pneumonia in a patient with diabetic foot infection,” International Journal of Antimicrobial Agents, vol. 47, no. 5, pp. 414-415, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Uppal, K. L. LaPlante, M. M. Gaitanis, M. D. Jankowich, and K. E. Ward, “Daptomycin-induced eosinophilic pneumonia - a systematic review,” Antimicrobial Resistance and Infection Control, vol. 5, no. 1, article 55, 2016. View at Publisher · View at Google Scholar · View at Scopus